
David Weinstock/LinkedIn
Jul 3, 2025, 16:19
David Weinstock Has Been Appointed Head of the Oncology Disease Translational Area in pRED at Roche
David Weinstock, Senior Vice President at Roche, shared a post on LinkedIn:
“I am thrilled to join Roche as Head of the Oncology Disease Translational Area (DTA) in Pharma Research and Early Development (pRED) in Basel, Switzerland.
Roche’s commitment to turning science into breakthroughs is inspiring. The opportunities to transform the lives of people with cancer have never been greater. I’m humbled to lead an incredible team of scientists and clinicians, working closely with our colleagues across Roche, Genentech, and Chugai Pharmaceutical, to discover, innovate, and develop the next generation of cancer therapies.”
More posts featuring Roche.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 3, 2025, 16:01
Jul 3, 2025, 13:19
Jul 3, 2025, 12:37
Jul 3, 2025, 12:18